IQV

IQVIA Holdings Inc

Oct 20 • 04:00PM ET

212.05

+7.50 3.67 %

Healthcare • Diagnostics & Research • USA • NYSE

| Held by: VTI VOO VO IVV SPY VTV XLV IBB VOE RSP

Index	S&P 500	P/E	30.72	EPS (ttm)	6.90	Insider Own	0.86%	Shs Outstand	170.00M	Perf Week	4.06%
Market Cap	36.05B	Forward P/E	16.51	EPS next Y	12.85	Insider Trans	-0.43%	Shs Float	168.53M	Perf Month	13.26%
Enterprise Value	49.57B	PEG	3.73	EPS next Q	2.98	Inst Own	101.26%	Short Float	2.67%	Perf Quarter	13.17%
Income	1.24B	P/S	2.30	EPS this Y	6.68%	Inst Trans	4.85%	Short Ratio	2.80	Perf Half Y	50.16%
Sales	15.70B	P/B	6.24	EPS next Y	8.20%	ROA	4.50%	Short Interest	4.49M	Perf YTD	7.91%
Book/sh	33.99	P/C	16.48	EPS next 5Y	8.24%	ROE	19.80%	52W High	237.21 -10.61%	Perf Year	-9.01%
Cash/sh	12.87	P/FCF	17.93	EPS past 3/5Y	14.76% 50.90%	ROIC	6.13%	52W Low	134.65 57.49%	Perf 3Y	20.34%
Dividend Est.	-	EV/EBITDA	14.66	Sales past 3/5Y	3.54% 6.79%	Gross Margin	27.09%	Volatility	2.84% 3.13%	Perf 5Y	27.29%
Dividend TTM	-	EV/Sales	3.16	EPS Y/Y TTM	-10.72%	Oper. Margin	14.40%	ATR (14)	5.94	Perf 10Y	202.54%
Dividend Ex-Date	-	Quick Ratio	0.84	Sales Y/Y TTM	3.53%	Profit Margin	7.88%	RSI (14)	66.83	Recom	1.48
Dividend Gr. 3/5Y	- -	Current Ratio	0.84	EPS Q/Q	-22.02%	SMA20	7.34%	Beta	1.32	Target Price	222.78
Payout	0.00%	Debt/Eq	2.72	Sales Q/Q	5.27%	SMA50	10.57%	Rel Volume	1.04	Prev Close	204.55
Employees	88000	LT Debt/Eq	2.49	Earnings	Oct 28 BMO	SMA200	19.57%	Avg Volume	1.60M	Price	212.05
IPO	May 09, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.42% 1.19%	Trades		Volume	1,671,153	Change	3.67%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-09-25	Upgrade	HSBC Securities	Hold → Buy	$235
Sep-09-25	Upgrade	Jefferies	Hold → Buy	$225
Apr-25-25	Downgrade	HSBC Securities	Buy → Hold	$160
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight	$170
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight	$250
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform	$275
Jul-24-24	Downgrade	Jefferies	Buy → Hold	$266 → $242
Jun-06-24	Initiated	Goldman	Buy	$270
Feb-26-24	Initiated	Leerink Partners	Outperform	$290
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy	$285
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral	$248 → $202
Sep-06-23	Initiated	HSBC Securities	Buy	$260
Mar-17-23	Initiated	Truist	Buy	$265
Dec-06-22	Initiated	Cowen	Outperform	$251
Nov-17-22	Downgrade	Citigroup	Buy → Neutral	$275 → $245
Aug-25-22	Initiated	Credit Suisse	Outperform	$300
Jul-15-22	Initiated	SVB Leerink	Outperform	$256

Show Previous Ratings

Oct-20-25 01:35PM	Why IQVIA (IQV) Stock Is Trading Up Today (StockStory)
Oct-15-25 04:25AM	What to Expect From IQVIA Holdings Next Quarterly Earnings Report (Barchart)
Oct-10-25 12:00AM	3 Reasons to Sell IQV and 1 Stock to Buy Instead (StockStory)
Oct-09-25 09:37AM	Oracle initiated, Roblox upgraded: Wall Street's top analyst calls (The Fly)
Oct-01-25 06:48PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research) +7.29%
04:01PM	Loading…
04:01PM	Why IQVIA (IQV) Stock Is Trading Up Today (StockStory)
10:10AM	Is Veeva's Vault CRM Emerging as the Standard for Top Biopharma? (Zacks)
Sep-30-25 04:15PM	IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025 (Business Wire) +5.10%
Sep-29-25 09:43AM	What Makes IQVIA (IQV) an Attractive Investment? (Insider Monkey)
Sep-19-25 09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
08:58AM	What Makes IQVIA (IQV) a Good Investment? (Insider Monkey)
Sep-16-25 08:00AM	IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships (Business Wire)
Sep-11-25 02:16PM	Why IQVIA (IQV) Stock Is Up Today (StockStory)
06:09AM	How Is IQVIA Holdings' Stock Performance Compared to Other Health Tech Stocks? (Barchart)
Sep-10-25 08:00AM	IQVIA Announces Launch of Clinical Trial Financial Suite, a Next-Generation Platform for Integrated Financial Management (Business Wire)
04:54AM	Loading…
04:54AM	IQVIA Holdings Inc. (IQV) and Flagship Pioneering Partner to Accelerate Growth of Breakthrough Life Sciences Companies (Insider Monkey)
Sep-09-25 12:11PM	Jefferies backs IQVIA and Charles River, cuts ICON on customer losses (Investing.com)
Sep-03-25 09:40AM	Here's Why IQVIA Holdings (IQV) is a Strong Value Stock (Zacks)
Sep-02-25 09:00AM	IQVIA Announces CFO Transition in Early 2026 (Business Wire)
Aug-29-25 11:30AM	Why Is DexCom (DXCM) Down 7% Since Last Earnings Report? (Zacks)
Aug-28-25 08:00AM	IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies (PR Newswire)
Aug-27-25 09:55AM	IQVIA Holdings Inc. (IQV): A Bull Case Theory (Insider Monkey)
Aug-22-25 08:29AM	What Are Wall Street Analysts' Target Price for IQVIA Holdings Stock? (Barchart)
Aug-21-25 11:30AM	IQVIA (IQV) Down 1.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Aug-18-25 11:31PM	Q2 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
09:00AM	IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes (Business Wire)
Aug-14-25 09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
02:42AM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Aug-13-25 10:57AM	UMAC Gears Up to Report Q2 Earnings: What's in the Offing? (Zacks)
Aug-11-25 09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
05:19AM	Loading…
05:19AM	Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion (PR Newswire)
Aug-06-25 06:42PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
12:24PM	Avis Budget Stock Declines 22% Since Reporting Q2 Earnings Miss (Zacks)
Aug-05-25 12:23PM	Gartner Earnings Surpass Estimates in Q2, Revenues Increase Y/Y (Zacks)
Jul-30-25 10:42AM	Verisk Earnings & Revenues Surpass Estimates in Q2, Increase Y/Y (Zacks)
Jul-29-25 12:44PM	WM Earnings & Revenues Beat Estimates in Q2, Increase Y/Y (Zacks)
12:41PM	Fiserv Q2 Earnings Beat Estimates on Strong Margins, Revenues Miss (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
01:34AM	5 Revealing Analyst Questions From IQVIA's Q2 Earnings Call (StockStory)
Jul-28-25 10:45AM	IQVIA (IQV) Reliance on International Sales: What Investors Need to Know (Zacks)
Jul-24-25 06:37PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
11:17AM	Veeva's Vault Vision: Can It Thrive After Parting With Salesforce? (Zacks)
Jul-23-25 02:23PM	IQVIA Holdings (IQV) Snaps 2-Day Losses on Higher-than-Expected Earnings (Insider Monkey)
01:31PM	Why IQVIA (IQV) Stock Is Up Today (StockStory)
09:58AM	Fiserv's Q2 Earnings Surpass Estimates, Revenues Increase Y/Y (Zacks)
08:37AM	Stock Market News for Jul 23, 2025 (Zacks)
03:08AM	IQVIA Holdings Inc (IQV) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic AI ... (GuruFocus.com)
01:32AM	IQV Q2 Deep Dive: AI Initiatives and Pipeline Growth Drive Outperformance Amid Margin Pressures (StockStory)
Jul-22-25 05:55PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research) +17.88%
04:38PM	S&P 500 Gains & Losses Today: Homebuilder Stocks Soar; Lockheed Martin Loses Altitude (Investopedia)
04:06PM	Medpace Surges 55% On 'Shockingly Strong' Report; Pulling Iqvia Higher (Investor's Business Daily)
02:53PM	IQVIA Leads S&P 500 Gainers on Better-Than-Expected Earnings (Investopedia)
12:23PM	Top Stock Movers Now: GM, Lockheed Martin, IQVIA, DR Horton, and More (Investopedia)
12:15PM	IQVIA Earnings & Revenues Beat Estimates in Q2, Rise Y/Y (Zacks)
11:55AM	Why IQVIA (IQV) Stock Is Trading Up Today (StockStory)
09:08AM	Iqvia Surges As 'Pluses' Outweigh 'Minuses' In Its Second-Quarter Report (Investor's Business Daily)
08:15AM	IQVIA Holdings (IQV) Q2 Earnings and Revenues Surpass Estimates (Zacks)
07:37AM	IQVIA (NYSE:IQV) Beats Q2 Sales Targets, Stock Soars (StockStory)
07:16AM	IQVIA: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Second-Quarter 2025 Results (Business Wire)
Jul-20-25 11:02PM	IQVIA Earnings: What To Look For From IQV (StockStory)
Jul-17-25 09:15AM	Countdown to IQVIA (IQV) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
08:52AM	What Makes IQVIA Holdings (IQV) an Investment Bet? (Insider Monkey)
08:08AM	Is IQVIA Holdings (IQV) an Attractive Investment Opportunity? (Insider Monkey)
Jul-16-25 10:00AM	Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:42AM	IQVIA Gears Up to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-15-25 05:06PM	Top Stock Reports for Amazon.com, Meta Platforms & Shopify (Zacks)
10:00AM	IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy? (Zacks)
12:05AM	3 Reasons IQV is Risky and 1 Stock to Buy Instead (StockStory)
Jul-11-25 09:45AM	Why IQVIA Holdings (IQV) is a Top Growth Stock for the Long-Term (Zacks)
Jul-10-25 11:40AM	IQVIA Unveils New Custom AI Agents with NVIDIA (Insider Monkey)
09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jul-09-25 11:52AM	Veeva Expands Market Reach Through Targeted Strategic Partnerships (Zacks)
Jul-08-25 12:05PM	VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait? (Zacks)
09:34AM	Healthcare's $110B AI Surge Is Picking Up Speed--and It's Just the Beginning (PR Newswire)
05:08AM	What to Expect From IQVIA Holdings' Q2 2025 Earnings Report (Barchart)
Jul-02-25 10:05AM	VEEV Integrates GenAI in Vault Platform to Drive Workflow Automation (Zacks)
Jul-01-25 07:00AM	IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025 (Business Wire)
Jun-30-25 12:39AM	3 Healthcare Stocks Skating on Thin Ice (StockStory)
Jun-27-25 09:15AM	Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last? (Zacks)
Jun-26-25 06:01PM	The Top 5 Analyst Questions From IQVIA's Q1 Earnings Call (StockStory)
10:15AM	Trump Vows To Cut 'The Best Deal' On Drug Prices. What To Expect. (Investor's Business Daily)
Jun-17-25 10:18AM	AI Healthcare Funding Surges as Real-World Rollouts Hit Pharmacies, Hospitals, and Providers (PR Newswire)
Jun-16-25 11:34PM	Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) (StockStory)
09:00AM	IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for 'Best Mobile App for Patient Engagement' (Business Wire)
Jun-11-25 07:00AM	IQVIA Launches New AI Agents for Life Sciences and Healthcare (Business Wire)
Jun-05-25 11:44AM	Doximity Declines 4.4% in a Month: How to Play the Stock Now? (Zacks)
Jun-02-25 04:37PM	IQVIA Announces Pricing of Senior Notes (Business Wire)
08:10AM	IQVIA Announces Offering of Senior Notes (Business Wire)
May-31-25 03:00AM	Ipca Laboratories Ltd (BOM:524494) Q4 2025 Earnings Call Highlights: Strong Domestic Growth and ... (GuruFocus.com)
May-27-25 07:00AM	Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF (PR Newswire)
May-19-25 08:48AM	IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty (StockStory)
05:40AM	IQVIA and SCRI partner to enhance oncology trials (Clinical Trials Arena)
May-16-25 08:00AM	IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials (Business Wire)
May-14-25 04:54PM	S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal (Investopedia) -5.88%
May-13-25 09:16AM	Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends (Zacks)
May-07-25 06:03PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
04:15PM	IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13 (Business Wire)
03:12AM	IQVIA Holdings Inc (IQV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
02:44AM	Q1 2025 IQVIA Holdings Inc Earnings Call (Thomson Reuters StreetEvents)

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cherofsky Keriann	See Remarks	Jul 23 '25	Sale	191.53	549	105,150	2,910	Jul 25 05:01 PM
Sherbet Eric	See Remarks	Jul 23 '25	Option Exercise	97.20	11,870	1,153,764	32,978	Jul 25 05:00 PM
Sherbet Eric	See Remarks	Jul 23 '25	Sale	190.05	5,800	1,102,290	27,178	Jul 25 05:00 PM
ERIC SHERBET	Officer	Jul 23 '25	Proposed Sale	190.05	5,800	1,102,262		Jul 23 05:53 PM
KERIANN CHEROFSKY	Officer	Jul 23 '25	Proposed Sale	191.53	549	105,150		Jul 23 04:01 PM
BOUSBIB ARI	See Remarks	Feb 10 '25	Option Exercise	65.16	40,000	2,606,400	837,083	Feb 12 05:11 PM
DANHAKL JOHN G	Director	Dec 03 '24	Buy	200.58	1,275	255,740	1,275	Feb 07 07:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IQV

IQVIA Holdings Inc

Upgrade your FINVIZ experience